RAMP2 and breast carcinoma: CCK-8 assays demonstrated that ADM2 knockdown significantly suppressed the proliferation of BT-549 and MDA-MB-231 cells, while overexpression of RAMP2 also inhibited proliferation across multiple breast cancer cell lines (Figure 5c,d).